Stoke Therapeutics (STOK) Net Equity Issued and Repurchased (2018)
Stoke Therapeutics (STOK) posted quarterly Net Equity Issued and Repurchased of $90.2 million for Q4 2018, up 574.19% quarter-over-quarter from $13.4 million in Q3 2018.
Stoke Therapeutics (STOK) Net Equity Issued and Repurchased (2018) Analysis & Trends
Stoke Therapeutics' Net Equity Issued and Repurchased history runs 1 years deep, the most recent figure standing at $90.2 million for Q4 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 49.20 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 141.90 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Stoke Therapeutics | 1.95 Bn | 1.66 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2018 | 90.15 Mn |
| Dec 31, 2018 | 90.15 Mn |
| Sep 30, 2018 | 13.37 Mn |
| Sep 30, 2018 | 13.37 Mn |